Chris Spears, frustrated by a lack of available obesity medication, turned to online alternatives and established OrderlyMeds, a telehealth company. Launched in January 2024, it services 40,000 patients monthly by connecting them to healthcare providers for prescriptions filled by compounding pharmacies. This market arose due to FDA regulations allowing the production of compounded drugs in short supply. Despite a past shortage of popular drugs like Wegovy and Zepbound, the demand drove innovation. With the return of availability, many compounding pharmacies are ceasing production, reflecting a dynamic landscape in obesity medication access.
"When Chris Spears' pharmacy didn't have the obesity drug his doctor prescribed, he found alternatives online, leading to the idea for his telehealth company OrderlyMeds."
"The FDA allows specialized pharmacies to make copies of brand-name drugs in short supply, creating a market for compounded alternatives."
Collection
[
|
...
]